Anti-TNF-alpha agents have been hypothesized to display opposing effects on autoimmune disorders, having the ability to induce or treat such disorders, depending on the immunological profile and levels of IL-4 and IFN-gamma [76]. This evidence concerns the gene TNF and autoimmune disease.